Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

CompletedOBSERVATIONAL
Enrollment

537

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

January 13, 2025

Study Completion Date

January 13, 2025

Conditions
Obesity
Trial Locations (22)

11374

Steven Batash, M.D., P.C., New York

20191

Endoscopic Wellness Center of America, Reston

20876

The Silhouette Clinic, Germantown

21045

Gastro Center of Maryland, Columbia

22182

Advanced Gastroenterology & Hepatology of Greater Washington, Vienna

27513

True You Weight Loss, Cary

28501

Atlantic Medical Group, Kinston

30342

True You Weight Loss (Atlanta), Atlanta

33458

JSAPA, Jupiter

33606

Formation, Tampa

45241

JourneyLite Physicians, Cincinnati

55905

Mayo Clinic, Rochester

73072

NRHS Journey Clinic, Norman

79707

Basin Surgical, Midland

90292

Carson D Liu MD Medical Corp, Marina del Rey

98034

Transform Weight Loss, Seattle

07039

Reveal Weight Loss, Livingston

Weight Loss and Wellness Center, Livingston

07081

New Jersey Bariatric Center, Springfield

07470

New York Bariatric Group - Wayne Location, Wayne

00961

FRC Gastro, Bayamón

GI Offices of Dr. Rodriguez and Dr. Osorio, Bayamón

All Listed Sponsors
lead

Spatz FGIA, Inc

OTHER

NCT05086302 - Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study | Biotech Hunter | Biotech Hunter